Table 2.

Commercially available assays vs. assays not commercially available for clinical virology: targets of interest

Commercially interesting targets	Important in‐house viral targets to be developed
HIV type 1	HIV type 2
Hepatitis B virus	Epstein–Barr virus
Hepatitis C Virus	Herpes simplex virus types 1 and 2
Cytomegalovirus	Cytomegalovirus
Human papilloma virus	Herpesvirus type 6
	Varicella zoster virus
	Enterovirus
	Rhinovirus
	Influenza virus
	Coronavirus
	Respiratory syncitial virus
	Human metapneumovirus
	Adenovirus
	Parvovirus B19
	Astrovirus
	Calicivirus